Diagnosis and Management of Primary Biliary Cholangitis
American Journal of Gastroenterology: January 2019 – Volume 114 – Issue 1 – p 48–63
Younossi, Zobair M., MD, MPH, FACG, AGAF, FAASLD; Bernstein, David, MD; FAASLD, FACG, AGAF, FACP; Shiffman, Mitchell L., MD; Kwo, Paul, MD; Kim, W. Ray, MD; Kowdley, Kris V., MD; Jacobson, Ira M., MD
Abstract: Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC can cause debilitating symptoms including fatigue and pruritus and, if left untreated, is associated with a high risk of cirrhosis and related complications, liver failure, and death. Recent changes to the PBC landscape include a name change, updated guidelines for diagnosis and treatment as well as new treatment options that have recently become available. Practicing clinicians face many unanswered questions when managing PBC. To assist these healthcare providers in managing patients with PBC, the American College of Gastroenterology (ACG) Institute for Clinical Research & Education, in collaboration with the Chronic Liver Disease Foundation (CLDF), organized a panel of experts to evaluate and summarize the most current and relevant peer-reviewed literature regarding PBC. This, combined with the extensive experience and clinical expertise of this expert panel, led to the formation of this clinical guidance on the diagnosis and management of PBC.